Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects
Completed
Crowley Carter Foundation
Phase 2
2003-01-01
This study is an open-label trial of trihexyphenidyl in children with upper extremity
dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to
0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of
upper extremity function.
Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects
Completed
Don and Linda Carter Foundation
Phase 2
2003-01-01
This study is an open-label trial of trihexyphenidyl in children with upper extremity
dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to
0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of
upper extremity function.
Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects
Completed
United Cerebral Palsy Foundation
Phase 2
2003-01-01
This study is an open-label trial of trihexyphenidyl in children with upper extremity
dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to
0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of
upper extremity function.
Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects
Completed
University of Southern California
Phase 2
2003-01-01
This study is an open-label trial of trihexyphenidyl in children with upper extremity
dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to
0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of
upper extremity function.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
